Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

Novartis strengthens links with BeiGene in a deal that could be worth up to $1bn

Novartis is to pay $300m upfront to BeiGene in a multifaceted deal to enhance its oncology portfolio and expand coverage of the Chinese market

- PMLiVE

AstraZeneca’s Saphnelo to be approved in Europe for lupus

The EMA is set to approve the first new treatment for systemic lupus erythematosus in Europe in more than a decade

- PMLiVE

The Communiqué Awards welcome Fiona McMillan and Jeremy Clark as the new co-chairs of the judging panel

The previous co-chairs Louise Dunn and Annabelle Sandeman have stepped down after three years

- PMLiVE

Can tobacco companies really reinvent themselves as healthcare companies?

A surprising move by key player, Phillip Morris, has called attention to the start of a new era for the tobacco industry. But can tobacco companies reinvent themselves as healthcare...

Say Communications

- PMLiVE

Tezspire approved in US for severe asthma

AstraZeneca and Amgen’s monoclonal antibody Tezspire is now available to control dangerous exacerbations in all adults and children aged 12 years and above with severe asthma

- PMLiVE

US prefers mRNA COVID-19 vaccines over J&J

Citing concerns over blood clots, Americans are now advised that should get the Pfizer-BioNTech or Moderna vaccines in preference to Johnson and Johnson vaccine

- PMLiVE

Emergency use of Paxlovid allowed in Europe

The EMA has issued advice to member states on potentially pre-approval use of Pfizer’s anti-COVID-19 treatment Paxlovid while a rolling review of data is ongoing

Biogen Idec building

Five years needed to confirm the benefit of Aduhelm

Biogen and Eisai have announced plans for a global, phase 3 clinical trial to confirm the long-term clinical benefit of Aduhelm treatment against Alzheimer’s disease

Global Marketing, Technology, and Innovation

Jim Lefevere, Director of Global Marketing Services at Roche, discusses the changes in digital marketing strategies, workflow, team dynamics, and required skill sets among Pharma teams brought on by COVID-19....

Impetus Digital

Train Your Brain for Success

Max Newlon, President of Brain Co., discusses everything from meditation practices and behavioral science to the use of technology in assessing and treating mental health conditions. He also delves into...

Impetus Digital

- PMLiVE

Sanofi/GSK vaccine boosts immune response

The vaccine boosted neutralising antibodies by 9 to 43-fold regardless of which vaccine was given as a primary course

- PMLiVE

FDA approves first drug to prevent graft-versus-host disease

Bristol Myers Squibb’s arthritis drug, Orencia, can now be given to adults and children undergoing stem cell transplants to prevent the life-threatening condition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links